Associate Professor of Psychology Zach Walsh has helped conduct the most comprehensive evaluation of the safety and effectiveness of MDMA-assisted psychotherapy for PTSD.
An international study involving researchers from UBC Okanagan has shown that MDMA, also known as ecstasy, may be a valuable tool for treating post-traumatic stress disorder (PTSD).
Published recently in Psychopharmacology, the study demonstrated substantial improvements in individuals who had not responded to prior treatments, explains UBCO Associate Professor of Psychology Zach Walsh. This is also, he adds, the most comprehensive evaluation of the safety and effectiveness of MDMA-assisted psychotherapy for PTSD.
“PTSD symptoms decreased after one session of MDMA together with psychotherapy,” says Walsh, study co-author. He adds that 54 per cent of participants no longer met PTSD criteria after two sessions and that there was also improvement in their symptoms of depression.
The response of participants to MDMA-assisted psychotherapy was compared to those who received small doses or non-drug psychotherapy.
“These findings are promising and indicate the needed for larger studies,” says Walsh. “Too many people with PTSD struggle to find effective treatment, and use of MDMA in a supportive environment with trained mental health professionals could be an important addition to our treatment options.”
Ecstasy, also known as Molly, is the nickname for MDMA—a synthetic drug made from a combination of methylenedioxy-methamphetamine. It is a controlled, illegal drug in Canada classified as a stimulant with hallucinogenic properties.
Walsh, as well as researchers from the United States, Switzerland and Israel, examined the results from six clinical trials, involving 103 people. Trial participants included men and women with chronic, treatment-resistant PTSD from a wide variety of causes.
Based on these results, the US Food and Drug Administration granted breakthrough therapy designation to MDMA-assisted psychotherapy for PTSD, acknowledging that it “may demonstrate substantial improvement over existing therapies” and agreeing to expedite its development and review.
The first of two more in-depth clinical trials of MDMA-assisted psychotherapy for PTSD began enrolling participants in November 2018 and aims to have 100-150 volunteers across 15 sites in the US, Canada, and Israel. The second trial will take place after an interim analysis of the data from the first trial, and will enrol an additional 100-150 participants. European trials are planned to start in the near future.
Nearly four per cent of all people worldwide will suffer from PTSD during their lifetime. PTSD can be a debilitating disorder, with symptoms including intrusive thoughts and memories, negative effects on thinking and mood, depression, hyperarousal and reactivity, and avoidance. People with PTSD can experience much lower quality of life and relationships, related mental health conditions and suicidal tendencies.
Learn more: ‘Ecstasy’ shows promise for post-traumatic stress treatment
The Latest on: PTSD treatment
via Google News
The Latest on: PTSD treatment
- PTSD, Opiates, Cannabis, And The Journey Towards Recoveryon January 20, 2021 at 3:03 am
Research continues to prove a positive future for cannabis as an alternative pharmacological option. - Medical Marijuana ...
- Repeated Ketamine Infusions Linked to Rapid Relief of PTSDon January 18, 2021 at 11:22 am
In what investigators call the first randomized controlled trial of repeated ketamine infusion for chronic PTSD, the treatment was associated with significant symptom reduction after 2 weeks.
- BRAUN: Film offers alternative treatment suggestions for PTSDon January 17, 2021 at 4:48 pm
That statistic prompted actor and filmmaker Michael Gier to make a documentary called Wounded Heroes, a film that explores alternative treatments for PTSD — post-traumatic stress disorder. We ...
- Mental Health Matters: The effects of trauma and PTSDon January 17, 2021 at 5:45 am
In this last segment of the Mental Health Matters series, we look at the challenges and struggles people with Post-traumatic Stress Disorder, or PTSD, face, as well as some newer treatments that ...
- PTSD, COVID, and Healing Americaon January 17, 2021 at 2:22 am
Supporters of US President Donald Trump climb a wall during a protest against the certification of the 2020 presidential election ...
- DUSSK study reveals the challenges of designing a tailored drug treatment service for street sex workerson January 14, 2021 at 10:46 am
Street sex workers may require trauma treatment in combination with specialised drug treatment groups, a Bristol study has suggested. Trauma treatment is not usually readily available to sex workers, ...
- Phobias, paranoia and PTSD: Why virtual reality therapy is the frontier of mental health treatmenton January 14, 2021 at 12:12 am
Virtual reality is being used to treat a wide range of mental health problems. Meet some of the scientists who are pioneering VR therapy and the people who are benefitting from it.
- Struggling with depression or PTSD?Ketamine Colorado Springs has the solutionon January 13, 2021 at 2:00 pm
No one should have to struggle with depression and PTSD. The team at Ketamine Colorado Springs are changing lives for the better using their Ketamine treatment. Dr. Jana Gainok and Dr. Jeff Gainok ...
- Why PTSD May Plague Many Hospitalized Covid-19 Survivorson January 12, 2021 at 9:11 am
Scientists warn about the likelihood of post-traumatic stress disorder for patients discharged from the intensive care unit ...
- ANANDA Scientific and NYU Grossman School of Medicine Announce Clinical Trial Utilizing Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)on January 12, 2021 at 8:45 am
ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a new clinical trial evaluating the efficacy of ...
via Bing News
 help to treat post-traumatic stress disorder (PTSD)?){kind=link}
